Skip to content

SBI for PSM and PSD

Screening and Brief Intervention for Prescription Stimulant Misuse and Diversion: Refining and Piloting a Curriculum for College Health Providers

Status
Enrolling by invitation
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06923384
Enrollment
120
Registered
2025-04-11
Start date
2024-10-01
Completion date
2026-05-30
Last updated
2025-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prescription Stimulant Diversion, Prescription Stimulant Misuse

Keywords

prescription stimulants

Brief summary

A pilot randomized controlled trial to assess the feasibility, acceptability, and impact of screening and brief intervention to address prescription stimulant misuse and diversion among college students.

Detailed description

A screening and brief intervention including a control group, face-to-face group, and e-intervention group where the focus is prevention or brief intervention or referral to treatment related to students prescription stimulant misuse and diversion behaviors. Students will complete assessments at three time points, and the health providers who implement the intervention will also complete assessments.

Interventions

BEHAVIORALF2F

After T1 assessment, students meet with a trained provider and receive prevention or brief intervention. Students then complete assessments at two additional times.

BEHAVIORALeSBI

After T1 assessment, students watch and respond to a prevention or brief intervention video series. Students then complete assessments at two additional times.

BEHAVIORALControl

Students complete the assessments at each time point, but do not receive any intervention or informational material.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
California State University, Long Beach
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Participants are randomly assigned to one of three conditions: control, face-to-face intervention with trained providers, or e-Intervention that involves watching a video from a health provider and responding to questions.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Age 18 and student at the campus serving as the intervention site; Passive recruitment: Student has a scheduled appointment for a physical/wellness exam. Active recruitment: Student has a past 3 month history of PSM or PSD.

Exclusion criteria

Any eligible student who, during the course of the session, demonstrates the need for immediate mental health services, will have the study session terminated so that participant can receive needed care.

Design outcomes

Primary

MeasureTime frameDescription
Prescription Stimulant Misuse30 daysStudents report on their experience with prescription stimulant misuse behaviors. PSM is assessed at T1, pre-intervention, and T3, 30-Days post intervention.
Prescription Stimulant Diversion30 daysStudents report on their experience with prescription stimulant diversion behaviors. PSD is assessed at T1, pre-intervention, and T3, 30-Days post intervention.

Secondary

MeasureTime frameDescription
PSM Intentions30 daysIntention to engage in PSM is measured at T1 (pre-intervention), T2 (immediate post), and T3 (30 Day post intervention)
PSD Intentions30 daysIntention to engage in PSM is measured at T1 (pre-intervention), T2 (immediate post), and T3 (30 Day post intervention).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026